Cargando…
MCP-1 targeting: Shutting off an engine for tumor development
A large amount of research has proven that monocyte chemotactic protein-1 (MCP-1) is associated with different types of disease, including autoimmune, metabolic and cardiovascular diseases. In addition, several studies have found that MCP-1 is associated with tumor development. MCP-1 expression leve...
Autores principales: | Wang, Liang, Lan, Jinxin, Tang, Jiaping, Luo, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630816/ https://www.ncbi.nlm.nih.gov/pubmed/34868363 http://dx.doi.org/10.3892/ol.2021.13144 |
Ejemplares similares
-
A New Shut-Off
por: Dowd, J. Henry
Publicado: (1899) -
PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review
por: Song, Jiachun, et al.
Publicado: (2022) -
Cancer Energy Metabolism: Shutting Power off Cancer Factory
por: Kim, Soo-Youl
Publicado: (2018) -
Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma
por: Rana, Priyanka S., et al.
Publicado: (2023) -
Evolution of the shut-off steps of vertebrate phototransduction
por: Lamb, Trevor D., et al.
Publicado: (2018)